BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 18089654)

  • 1. DNA methylation biomarkers for blood-based colorectal cancer screening.
    Lofton-Day C; Model F; Devos T; Tetzner R; Distler J; Schuster M; Song X; Lesche R; Liebenberg V; Ebert M; Molnar B; Grützmann R; Pilarsky C; Sledziewski A
    Clin Chem; 2008 Feb; 54(2):414-23. PubMed ID: 18089654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
    deVos T; Tetzner R; Model F; Weiss G; Schuster M; Distler J; Steiger KV; Grützmann R; Pilarsky C; Habermann JK; Fleshner PR; Oubre BM; Day R; Sledziewski AZ; Lofton-Day C
    Clin Chem; 2009 Jul; 55(7):1337-46. PubMed ID: 19406918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer.
    He Q; Chen HY; Bai EQ; Luo YX; Fu RJ; He YS; Jiang J; Wang HQ
    Cancer Genet Cytogenet; 2010 Oct; 202(1):1-10. PubMed ID: 20804913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions.
    Tänzer M; Balluff B; Distler J; Hale K; Leodolter A; Röcken C; Molnar B; Schmid R; Lofton-Day C; Schuster T; Ebert MP
    PLoS One; 2010 Feb; 5(2):e9061. PubMed ID: 20140221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of colorectal cancer in urine using DNA methylation analysis.
    Bach S; Paulis I; Sluiter NR; Tibbesma M; Martin I; van de Wiel MA; Tuynman JB; Bahce I; Kazemier G; Steenbergen RDM
    Sci Rep; 2021 Jan; 11(1):2363. PubMed ID: 33504902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
    Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
    Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay.
    Grützmann R; Molnar B; Pilarsky C; Habermann JK; Schlag PM; Saeger HD; Miehlke S; Stolz T; Model F; Roblick UJ; Bruch HP; Koch R; Liebenberg V; Devos T; Song X; Day RH; Sledziewski AZ; Lofton-Day C
    PLoS One; 2008; 3(11):e3759. PubMed ID: 19018278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.
    Azuara D; Rodriguez-Moranta F; de Oca J; Sanjuan X; Guardiola J; Lobaton T; Wang A; Boadas J; Piqueras M; Monfort D; Galter S; Esteller M; Moreno V; Capellá G
    Inflamm Bowel Dis; 2013 Jan; 19(1):165-73. PubMed ID: 22532293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays.
    Li H; Du Y; Zhang D; Wang LN; Yang C; Liu B; Wang WJ; Shi L; Hong WG; Zhang L; Yang YX
    Oncol Rep; 2012 Jul; 28(1):99-104. PubMed ID: 22552777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
    Warren JD; Xiong W; Bunker AM; Vaughn CP; Furtado LV; Roberts WL; Fang JC; Samowitz WS; Heichman KA
    BMC Med; 2011 Dec; 9():133. PubMed ID: 22168215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of genes methylated with high frequency in colorectal cancer.
    Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
    BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
    Payne SR
    Epigenomics; 2010 Aug; 2(4):575-85. PubMed ID: 22121975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study.
    Ørntoft MB; Nielsen HJ; Ørntoft TF; Andersen CL;
    BMC Cancer; 2015 Oct; 15():819. PubMed ID: 26514170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
    Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
    PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
    Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
    Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia.
    Pedersen SK; Symonds EL; Baker RT; Murray DH; McEvoy A; Van Doorn SC; Mundt MW; Cole SR; Gopalsamy G; Mangira D; LaPointe LC; Dekker E; Young GP
    BMC Cancer; 2015 Oct; 15():654. PubMed ID: 26445409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
    Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
    PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.